CTNNB1 and neoplasm: In two tested samples, CTC-derived DNA revealed tumor-specific CTNNB1 mutations (codons 32–37 and 41–45), while the matched plasma cfDNA from the same patients tested negative for CTNNB1 mutations (Supplemental Table 6).